Global infusion pumps market to reach USD 39.57B by 2029

The “Global infusion pumps market (2023 Edition): Analysis by product type (Volumetric, ambulatory, insulin, PCA, syringe pumps, others), by indication, end use, by region, by country: Market insights and forecast (2019-2029)” report has been added to ResearchAndMarkets.com’s offering.

During the forecast period, 2024-2029, the Global Infusion Pumps market is expected to grow at a CAGR of 11%. The Global Infusion Pumps Market is expected to generate 39.57 billion by the end of 2029, up from USD 17.34 Billion in 2022.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).

Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast. The research study also looks at the market growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market’s evolution.

The market for infusion pumps has been witnessing consistent expansion as a result of factors such as an ageing population, a rising incidence of chronic illnesses, and the demand for precise and regulated medication administration. A range of infusion pumps are available, encompassing volumetric infusion pumps, syringe pumps, insulin pumps, and others, with each kind fulfilling a distinct role.

The continuous advancement of healthcare technology has resulted in the emergence of increasingly sophisticated and effective infusion pumps. The increasing significance of smart infusion pumps equipped with features such as remote monitoring connectivity and dosage error reduction capabilities has been seen.

The global growth of the infusion pumps market can be attributed to many factors, including the enhanced accessibility to healthcare services in emerging economies, the upward trend in healthcare spending, and the notable increase in the elderly population across various regions.

The companies analysed in the report include

• Medtronic PLC
• Johnson & Johnson
• Baxter International
• B. Braun
• Fresenius
• ICU Medical
• Becton, Dickinson and Co
• F. Hoffmann-La Roche AG
• Insulet Corporation
• Nipro

Research and Markets